Breast

Novartis Breast Cancer Drug Kisqali Wins European Panel Backing

(Reuters) June 23, 2017 - A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.

read article

U.S. Physicians Move to More Flexible Mammogram Schedule

(Reuters Health) June 22, 2017 - Women at average risk for breast cancer should be offered screening mammograms every year or two starting at age 40 and they should start regular screening no later than age 50, an influential U.S. group of obstetricians and gynecologists said on Thursday.

read article

Making Sense of Breast Cancer, Health Insurance and Time Off Work

(U.S. News & World Report/HealthDay News) June 22, 2017 — Balancing work, treatment and recovery can be challenging for some patients.

read article

First Opinion: Landmark FDA Approval Bolsters Personalized Medicine

(STAT) June 21, 2017 - Our understanding of cancer has been morphing from a tissue-specific disease — think lung cancer or breast cancer — to a disease characterized more by specific genes or biomarkers than by location.

read article

Arizona Chapter of Komen Breast Cancer Foundation Is Closing

(U.S. News & World Report/Associated Press) June 22, 2017 - After 24 years, the Arizona chapter of the Susan G. Komen breast cancer foundation will close on July 31 because of dwindling donations and event participation.

read article

Most Precise Estimates Ever of Cancer Risks With BRCA

(Medscape Medical News) June 20, 2017 - While it has been well established that carriers of the BRCA1 and BRCA2 mutations face a higher risk for breast and ovarian cancer, most studies to date have been retrospective.

read article (free registration required)

Hair Dyes Tied to Higher Breast Cancer Risk

(WebMD/HealthDay News) June 20, 2017 - The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost the odds in white women.

read article

Is Pfizer Discriminating Against Korean Consumers?

(Korea Biomedical Review) June 21, 2017 - Pfizer has come under fire in Korea, as a group of breast cancer patients criticizes the U.S. pharmaceutical giant for discriminating against Korean consumers compared with their foreign counterparts, including Britons, industry sources said Wednesday.

read article

NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds

(NCCN) June 20, 2017 - As published in JNCCN, a Siteman Cancer Center study uncovered potential to significantly improve NCCN Guidelines-concordant care in patients with early-stage breast cancer.

read press release

Possible Role for Immunotherapy in Early-Stage Breast Cancer

(Medscape Medical News) June 15, 2017 - Immune checkpoint blockade may have a role in the presurgery treatment of high-risk, early-stage breast cancers, according to results from a phase 2 trial presented here at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting.

read article (free registration required)

Trastuzumab Emtansine Improves Survival in Previously Treated Metastatic HER2-Positive Breast Cancer

(NCI/Cancer Currents Blog) June 14, 2017 - Final results from two international randomized trials confirm that trastuzumab emtansine (Kadcyla®) improves survival for patients with metastatic breast cancer that overexpresses the HER2 protein.

read article

UK Will Pay for Roche Breast Cancer Drug at Center of Price Row

(Reuters) June 15, 2017 - A Roche breast cancer drug at the center of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal between the company and the National Health Service, the country's cost watchdog said on Thursday.

read article

First Opinion: Too Much Medical Care: Bad For You, Bad For Health Care Systems

(STAT) June 15, 2017 - The harder we look, the more cancer we find.

read article

Lots of Unneeded Interventions in Early Breast Cancer

(Medscape Medical News) June 14, 2017 - Among women who have been treated for early-stage breast cancer and are under surveillance, more than a third (37%) receive what are very likely to be unneeded tumor-marker blood tests, according to new research from the state of Washington.

read article (free registration required)

Already-promising Cancer Drug May Have Wider Applicability

(Dana-Farber) June 12, 2017 - New study shows CDK4/6-inhibiting drug palbociclib not only arrests cancer cell division but can also induce cancer cell death in tumors with high level of key protein. Discovery raises prospect of clinical test to identify patients who can gain particular benefit from CDK4/6 inhibitors.

read press release

Pfizer, Roche and Aspen Face South Africa Probe Over Cancer Drug Prices

(Reuters) June 13, 2017 - South Africa's competition watchdog has launched an investigation into three pharmaceutical companies suspected of over-charging for cancer medicines, the agency's chief said on Tuesday.

read article

Metastatic Breast Cancer Cells Use Hedgehog To ‘Evilize’ Docile Neighbors

(UCCC/Colorado Cancer Blogs) June 12, 2017 - CU Cancer Center study pinpoints promising link in the chain of hedgehog signaling that, when broken, could reduce the metastatic potential of breast cancer.

read article

Four New Medicines Win Nod for NHS Scotland

(PharmaTimes [UK]) June 13, 2017 - The Scottish Medicines Consortium has accepted four new medicines for routine use by NHS Scotland, offering patients new options for kidney cancer, liver disease and the prevention of nausea and vomiting.

read article

Roche CEO Still Optimistic On New Breast Cancer Drug

(Reuters) June 11, 2017 - Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker's chief executive said in an interview published on Sunday.

read article

Q BioMed Inc Announces Commercialization of Non-Narcotic Metastatic Cancer Pain Drug

(Q BioMed) June 7, 2017 — Q BioMed Inc., is very pleased to announce that the company has initiated production of Strontium-89 Chloride, a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain.

read corporate press release
Next Page